[HCS PHARMA] Our dermocosmetology services will be presented at In-Cosmetics Paris

March 2016

Nous sommes très heureux de vous inviter au salon "in-cosmetics" qui se tiendra à Paris du 12 au 14 avril, où vous pourrez nous retrouver stand P43. Nous y présenterons nos services dédiés à la dermocosmétologie (Photoaging, Moisturizing, Wound healing) ainsi que nos tests spécifiques.
Et n'oubliez pas de vous inscrire à la prochaine rencontre ELRIGfr sur Rennes, les 3 et 4 mai prochain, qui portera sur les thèmes “Lab Automation, Formulation & Phenotypic screening”.

We are very pleased to invite you to the "in-cosmetics" event to be held in Paris from 12 to 14 April. We will be present at booth P43, and will present our services in dermocosmetology like Photoaging, Moisturizing, Wound healing or our Cosmetics custom assays. Feel free to contact us to get more informations.
And don't forget to register to the next ELRIGfr event will take place in Rennes, may 3 and 4, which will focus on “Lab Automation, Formulation & Phenotypic screening”.

In-Cosmetics Paris, April 12 to 14

Come and visit us at in-cosmetics, the meeting of the major groups of cosmetics, Porte de Versailles in Paris. We will exhibit Stand P43 within the Cosmetic Valley in partnership with Bretagne Commerce International.

We will be happy to welcome and present you our services in phenotypic screening and cell imaging.

Our CEO talks about entrepreneurship and Brittany for femmesdebretagne.fr

We are really happy to be a part of the women’s network “Femmes de Bretagne”. This network aim to empower women who want to create companies, with kindness and respect. You can find more informations in french on this link : La charte “Femmes de Bretagne”

We want to thanks Anne-Gabrielle Marmignon for this interview.

Cell culture including microscaffolds and 3D matrices to enhance relevancy

Why contract research organizations (CROs), life sciences companies, and clinical research laboratories are beginning to embrace 3D system improvements such as microscaffolds and 3D matrices ? The scientific community aknowledge that 2D cell culture and the use of cell lines, that have been cultured for tens of years, are not the most relevant ones.

Multiplexing High Content Assay for toxicity testing

“Cell-based high-content screening (HCS) assays have become an increasingly attractive alternative to traditional in vitro and in vivo testing in pharmaceutical drug development and toxicological safety assessment. The time- and cost-effectiveness of HCS assays, combined with the organotypic nature of human induced pluripotent stem cell (iPSC)-derived cells, open new opportunities to employ physiologically relevant in vitro model systems to improve screening for potential chemical hazards.

Services

Explain us your requirements and we develop your assays to best meet your needs !

Why HCS ?

To target complex diseases (as cancer and neurodegenerative diseases), more than one target are needed and screening on complex model is recommended.

View this email in your browser

Website

Twitter

Google Plus